Spotlight on Progress
The ODP is working with U.S. Preventive Services Task Force (USPSTF) liaisons at the NIH to describe Institute and Center (IC) activities that address research gaps identified by the Task Force as having insufficient evidence to make a recommendation for or against a clinical preventive service. The goal is to identify areas in need of additional research, and coordinate with the ICs to address evidence gaps. The ODP will use a similar approach with the Community Preventive Services Task Force (CPSTF) to close prevention research gaps in community settings.
Learn more about the ODP’s partnership with the USPSTF .
The ODP partners with the U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion (ODPHP) to support national health initiatives, including Healthy People 2020. The ODP serves on the Healthy People Federal Interagency Workgroup and provides advice on numerous Healthy People activities to ensure that NIH input is provided.
The ODP hosted two Pathways to Prevention (P2P) workshops in 2014. These workshops identified research needs regarding the use of opioids in the treatment of chronic pain and for myalgic encephalomyelitis/chronic fatigue syndrome. For each workshop, a rigorous assessment of the available scientific evidence was conducted, and experts in the field presented their findings to an independent panel. Final reports from both workshops have been published.
The ODP can assist NIH Institutes and Centers by identifying prevention research needs and gaps, and prioritizing them on an ongoing basis. In this process, the ODP should make use of the variety of prevention research data sources available, including, but not limited to, NIH portfolio analysis and reports from other federal agencies and task forces. Regular engagement with stakeholders such as the U.S. Preventive Services Task Force (USPSTF), the Community Preventive Services Task Force (CPSTF), and the extramural prevention research community also will inform the identification of prevention research areas for investment or expanded effort by the NIH. In addition, the ODP will work closely with colleagues at the NIH to promote a research agenda that examines a variety of issues including health disparities and social determinants of health, as well as the role of the environment in disease prevention, and improves health across the life course.
The objectives supporting Strategic Priority II include working with stakeholders to identify needs for prevention research, a comparison of those needs with the current NIH portfolio, and collaboration with the NIH Institutes and Centers to prioritize gaps in prevention research for additional investment. Results of these efforts will be compiled and shared with others at the NIH to identify areas that warrant further study; the ODP also will use these results to guide its own co-funding decisions. Strategic Priority II relies on building collaborations between the ODP and NIH Institutes and Centers, federal agencies, nonfederal task forces and other organizations that routinely conduct systematic evidence reviews (e.g., USPSTF, CPSTF, Cochrane Collaborative, Institute of Medicine), existing evidence-based public health initiatives (e.g., Healthy People), and other stakeholders to identify, promote, and address needs in prevention research.
- Objective II.1: Work with stakeholders to identify needs in prevention research.
- Objective II.2: Compare those needs with the current NIH portfolio to identify gaps in prevention research (i.e., those areas that are not being addressed or have insufficient funding).
- Objective II.3: Work with the NIH Institutes and Centers to prioritize the prevention research gaps for investment or expanded effort.